Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02241213

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Fundación Cardiovascular de Colombia (from the registry)
Registry
  • NCT NCT02241213
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Colombia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02241213. Randomized; triple masking; primary purpose treatment. Start 2014-08 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of MTS-r on Speech Production in Non-fluent Aphasia Post-ischemic Stroke Patients
Acronym
Aphasia-ACV
Condition
Aphasia, Broca
Intervention (Device)
Transcranial Magnetic Stimulation (TMS-r)
Intervention (Device)
Placebo Transcranial Magnetic Stimulation
Lead sponsor
Fundación Cardiovascular de Colombia (class: other)
Collaborator
Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS) (class: other government)

Record details

Record id
cardio:ct-nct02241213
Content hash
da402daeb98da08ee6474b5a6ad7d9aac61398c43b59ac27d9f18c8f8c80453e